[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"soft-tissue-neoplasms\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:soft-tissue-neoplasms":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":25,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100591337","investigation-into-the-safety-and-efficacy-of-icg-labeled-fluorescence-imaging-technology-in-guiding-the-resection-of-bone-and-soft-tissue-tumors-100591337",false,"NCT06979115","Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors","ICG-BST","Inclusion Criteria:\n\n1. Histologically confirmed diagnosis of bone and soft tissue tumors (according to the WHO Classification of Tumours of Soft Tissue and Bone, 4th Edition).\n2. Medically fit to undergo surgical treatment based on preoperative evaluation.\n3. Absence of cardiovascular, anesthesia-related, or other surgical contraindications.\n\nExclusion Criteria:\n\n1. Presence of severe or chronic kidney, liver, or pulmonary diseases.\n2. Autonomous thyroid nodules or allergy to iodine\u002Fshellfish.\n3. Deemed unable to tolerate surgery based on preoperative evaluation.","ALL",{"count":18,"type":19},40,"ESTIMATED","OBSERVATIONAL","Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the incidence of adverse events and evaluate the safety of the protocol.",[23,24],"Bone Neoplasms","Soft Tissue Neoplasms",[26,27,28,29],"Soft tissue neoplasms","Bone neoplasms","Indocyanine green","Near-infrared","NOT_YET_RECRUITING","2025-05-12",{"date":33,"type":34},"2025-05-18","ACTUAL",{"date":36,"type":19},"2025-05-25",{"date":38,"type":19},"2028-12-31",{"name":40,"class":41},"Guangdong Provincial People's Hospital","OTHER"]